Structural and mechanistic basis of neutralization by a pan-hantavirus protective antibody

Author:

Mittler Eva1ORCID,Serris Alexandra2ORCID,Esterman Emma S.3ORCID,Florez Catalina45ORCID,Polanco Laura C.1,O’Brien Cecilia M.45ORCID,Slough Megan M.1ORCID,Tynell Janne67ORCID,Gröning Remigius6ORCID,Sun Yan8ORCID,Abelson Dafna M.9,Wec Anna Z.3ORCID,Haslwanter Denise1ORCID,Keller Markus10ORCID,Ye Chunyan11,Bakken Russel R.4,Jangra Rohit K.1ORCID,Dye John M.4,Ahlm Clas6ORCID,Rappazzo C. Garrett3ORCID,Ulrich Rainer G.1012ORCID,Zeitlin Larry9ORCID,Geoghegan James C.3,Bradfute Steven B.11ORCID,Sidoli Simone8ORCID,Forsell Mattias N.E.6ORCID,Strandin Tomas7ORCID,Rey Felix A.2ORCID,Herbert Andrew S.4ORCID,Walker Laura M.3ORCID,Chandran Kartik1ORCID,Guardado-Calvo Pablo2ORCID

Affiliation:

1. Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.

2. Institut Pasteur, Université Paris Cité, CNRS UMR3569, Structural Virology Unit, F-75015 Paris, France.

3. Adimab LLC, Lebanon, NH 03766, USA.

4. U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, MD 21702, USA.

5. The Geneva Foundation, Tacoma, WA 98402, USA.

6. Department of Clinical Microbiology, Umeå University, 90187 Umeå, Sweden.

7. Zoonosis Unit, Department of Virology, Medical Faculty, University of Helsinki, 00290 Helsinki, Finland.

8. Department of Biochemistry, Albert Einstein College of Medicine, Bronx, NY 10461, USA.

9. Mapp Biopharmaceutical Inc., San Diego, CA 92121, USA.

10. Institute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, 17493 Greifswald-Insel Riems, Germany.

11. Center for Global Health, Department of Internal Medicine, University of New Mexico Health Science Center, Albuquerque, NM 87131, USA.

12. Partner site: Hamburg-Lübeck-Borstel-Riems, German Centre for Infection Research (DZIF), 17493 Greifswald-Insel Riems, Germany.

Abstract

Emerging rodent-borne hantaviruses cause severe diseases in humans with no approved vaccines or therapeutics. We recently isolated a monoclonal broadly neutralizing antibody (nAb) from a Puumala virus–experienced human donor. Here, we report its structure bound to its target, the Gn/Gc glycoprotein heterodimer comprising the viral fusion complex. The structure explains the broad activity of the nAb: It recognizes conserved Gc fusion loop sequences and the main chain of variable Gn sequences, thereby straddling the Gn/Gc heterodimer and locking it in its prefusion conformation. We show that the nAb’s accelerated dissociation from the divergent Andes virus Gn/Gc at endosomal acidic pH limits its potency against this highly lethal virus and correct this liability by engineering an optimized variant that sets a benchmark as a candidate pan-hantavirus therapeutic.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3